Investigation of Key Genes and Pathways in Inhibition of Oxycodone on Vincristine-Induced Microglia Activation by Using Bioinformatics Analysis

الملخص EN

Introduction.

The neurobiological mechanisms underlying the chemotherapy-induced neuropathic pain are only partially understood.

Among them, microglia activation was identified as the key component of neuropathic pain.

The aim of this study was to identify differentially expressed genes (DEGs) and pathways associated with vincristine-induced neuropathic pain by using bioinformatics analysis and observe the effects of oxycodone on these DEG expressions in a vincristine-induced microglia activation model.

Methods.

Based on microarray profile GSE53897, we identified DEGs between vincristine-induced neuropathic pain rats and the control group.

Using the ToppGene database, the prioritization DEGs were screened and performed by gene ontology (GO) and signaling pathway enrichment.

A protein-protein interaction (PPI) network was used to explore the relationship among DEGs.

Then, we built the vincristine-induced microglia activation model and detected several DEG expressions by real-time polymerase chain reaction (PCR) and western blotting.

Meanwhile, the effects of different concentrations of oxycodone on inflammatory response in primary microglia induced by vincristine were observed.

Results.

A total of 38 genes were differentially expressed between normal and vincristine-treated rats.

GO and pathway enrichment analysis showed that prioritization DEGs are involved in cAMP metabolic process, inflammatory response, regulation of cell proliferation, and chemokine pathway.

The in vitro studies showed that vincristine had dose-dependent cytotoxic effects in microglia.

Compared to the control group, vincristine (0.001 μg/ml) could lead to inflammation in primary microglia induced by vincristine and upregulated the CXCL10, CXCL9, SFRP2, and PF4 mRNA and made an obvious reduction in IRF7 mRNA.

At protein levels, oxycodone (50, 100 ng/ml) decreased the expression of CXCL10 and CXCL9 in activated microglia.

Conclusion.

Our study obtained several DEG expressions and signaling pathways in the vincristine-induced neuropathic pain rat model by bioinformatics analysis.

Oxycodone could alleviate the vincristine-induced inflammatory signaling in primary microglia and downregulate some DEGs.

Further molecular mechanisms need to be explored in the future.